Here are relevant reports on : biopharmaceutical-cro-services-market
-
Biopharmaceutical Cell Culture Market by Product [Consumables (Media, Sera, Reagents; Accessories), Equipment (Bioreactors, Centrifuges, Filters, Incubators, Freezers)], Type (mAbs, Vaccines, Other), End User (Biopharma, CMOs) - Global Forecast to 2031
The global biopharmaceutical cell culture market, valued at USD 11.63 billion in 2025, stood at USD 12.81 billion in 2026 and is projected to advance at a resilient CAGR of 13.8% from 2026 to 2031, culminating in a forecasted valuation of USD 24.47 billion by the end of the period. The report profiles key players, including Thermo Fisher Scientific (US), Danaher (US), Sartorius AG (Germany), Merck KGaA (Germany), Corning Incorporated (US), FUJIFILM Holdings Corporation (Japan), and Eppendorf SE (Germany).
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Solvent Evaporation Market by Evaporator Type (Rotary Evaporator, Nitrogen Blow Down Evaporator, Centrifugal Evaporator), End-User (Pharmaceutical & Biopharmaceutical, Diagnostic Laboratories, Research & Academic Institute), Region - Global Forecast to 2024
The solvent evaporators market is expected to grow from USD 487 million in 2019 to USD 694 million by 2024, at a compound annual growth rate (CAGR) of 7.3%. during the forecast period.The prominent players in the solvent evaporators market include Yamato Scientific Co., Ltd. (Japan), BÜCHI Labortechnik AG (Switzerland), Biotage AB (Sweden), Heidolph Instruments GmbH & CO. KG (Germany), Labconco Corporation (US), Porvair plc (UK), IKA Works GmbH & Co. KG (Germany), Steroglass Srl (Italy), Organomation Associates, Inc. (US), KNF Neuberger, Inc. (US), BioChromato, Inc. (Japan), Radleys (UK), LabTech S.r.l. (Italy), Abel Industries Canada Ltd. (Canada), DOÐA Limited (Turkey), ANPEL Laboratory Technologies Inc. (China), Asahi Glassplant Inc. (Japan), EYELA (Japan), Pope Scientific, Inc. (US), and SP Industries, Inc. (UK).
- Published: November 2019
- Price: $ 4950
- TOC Available:
-
Filter Integrity Test Market by Test Type (Bubble Point, Diffusion, Water Flow), Mechanism (Manual, Automation), Filter Type (Air, Liquid), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, Academics) - Global Forecast to 2024
The Filter Integrity Test Market is projected to reach USD 79 million by 2024, growing at a CAGR of 5.0%. Factors such as increasing R&D spending, growth in the biopharmaceutical industry, and increasing purity requirements in the end-user market are driving the growth of the filter integrity test market. The major players in the filter integrity test market are Merck KGaA (Germany), Danaher Corporation/Pall Corporation (US), Sartorius (Germany), Donaldson Company (US), Parker Hannifin Corporation (US), Meissner Filtration Product (US), MDI Filtration Technologies (US), Thermo Fisher Scientific (US), Eaton Corporation (Ireland), and SH-Surway (China).
- Published: February 2019
- Price: $ 4950
- TOC Available:
-
Stable Isotope Labeled Compounds Market by Type (Carbon 13, D, Oxygen 18, N15), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical & Biopharmaceutical Companies, Academic institute), Region – Global Forecast to 2024
The global stable isotope labeled compounds market in terms of revenue was estimated to be worth $269 million in 2019 and is poised to reach $312 million by 2024, growing at a CAGR of 3.0% from 2019 to 2024. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: January 2020
- Price: $ 4950
- TOC Available:
-
Biopharmaceutical Process Analytical Technology Market by Modality (Spectroscopy: Raman, IR, NMR; Chromatography: HPLC, GC; MS, qPCR, NGS), Product (Analyzer, Sensor, Software), Mode (Online, At-line), Application (Biologics, CGT)- Global Forecast to 2031
The global biopharmaceutical process analytical technology market is projected to reach USD 4.32 billion by 2031, growing at a CAGR of 17.1% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Nanoparticle Analysis Market by Technology (DLS, NTA, XRD, SMPS, CPC, NSAM), Analysis Type (Size, Zeta Potential, Weight, Flow properties), End-user (Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutions) - Global Forecast to 2020
This report studies the global nanoparticle analysis market over the forecast period of 2015 to 2020. The market is expected to reach USD 91.1 Million by 2020, at CAGR of 5.4% from 2015 to 2020. Rising focus on nanotechnology research, continuous advancements in nanoparticle analysis technologies, and increasing government spending on pharmaceutical R&D in emerging nations are key factors fuelling the growth of the nanoparticle analysis market. Increasing demand for customized medical implants, requirement of less sample volume and sample preparation in advanced analytical technologies, and stringent regulatory guidelines for drug approval are some other prime factors offering growth opportunities for players in the nanoparticle analysis market. However, high cost of nanoparticle analysis instruments is one of the key restraints for the market growth.
- Published: November 2015
- Price: $ 4950
- TOC Available:
-
Cell Lysis Market / Fractionation Market by Product (Consumables (Enzymes, Detergent), Instruments (Sonicators)), Cell Type (Mammalian), Application (Protein Purification), End User (Biopharmaceutical & Biotechnology Companies) & Region - Global Forecast to 2026
The global cell lysis market growth is primed to transition from $2.9 billion in 2021 to $4.1 billion by 2026, showcasing a strong CAGR of 7.2%. Growth of the market is driven mainly by increasing government funding for research, the high prevalence of diseases, and a growing focus on personalised medicine.
- Published: March 2021
- Price: $ 4950
- TOC Available:
-
PVDF Membrane Market by Technology, Type (Hydrophobic, Hydrophilic), Application (General Filtration, Sample Preparation, Bead – Based Assays), End-Use Industry (Biopharmaceutical, Industrial, Food & Beverage), and Region - Global Forecast to 2027
The PVDF membrane market is expected to grow from USD 779 million in 2022 to USD 1,126 million by 2027, at a CAGR of 7.7% during the forecast period. The key players in this market are Arkema S.A. (France), Merck Millipore (US), KOCH Separation Solutions (US), Pall Corporation (US), Cytiva Life Science (US), CITIC Envirotech Pte Ltd (Singapore), Bio-Rad laboratories (US), Thermo Fisher Scientific Inc. (US), Membrane Solutions, LLC. (US), GVS Filter Technology (Italy), and Toray Industries, Inc. (Japan).
- Published: January 2023
- Price: $ 4950
- TOC Available:
-
Biopharmaceutical Contract Manufacturing Market by Service (Manufacturing, Fill-Finish), Type (Drug Substance, Drug Product), Scale (Clinical), Source (Mammalian), Therapy Area (Oncology), Molecule Type (mAbs, ADC, CGT, Vaccines) - Global Forecast to 2030
The global biopharmaceutical contract manufacturing market, valued at US$20.51 billion in 2024, stood at US$22.40 billion in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2025 to 2030, culminating in a forecasted valuation of US$34.15 billion by the end of the period. The growth is primarily driven by the rising demand for outsourcing services and an increasing need for biologics and biosimilars. However, challenges related to intellectual property rights are anticipated to pose barriers to market growth.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Healthcare Distribution Market by Type (Pharmaceutical (Brand-name, Generic, OTC, Vitamins), Medical Device, Biopharmaceutical (Vaccines, Monoclonal Antibodies)), End User (Retail Pharmacies, Hospital Pharmacies) & Region - Global Forecasts to 2024
The healthcare distribution market is projected to reach USD 1,048.4 billion by 2024, at a CAGR of 6.5%. The prominent players operating in the healthcare distribution market are McKesson Corporation (US), AmerisourceBergen Corporation (US), Cardinal Health, Inc. (US), Owens & Minor, Inc. (US), Morris and Dickson Co., LLC (US), KeySource Medical, Inc. (US), Rochester Drug Cooperative, Inc. (US), Henry Schein Inc. (US), Smith Drug Company (US), FFF Enterprises (US), Patterson Companies Inc. (US), Mutual Drug (US), Shanghai Pharmaceutical Group Co., Ltd. (China), Medline Industries (US), PHOENIX Group (Germany), and CuraScript SD (US).
- Published: June 2019
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
